Medivation and Pfizer to Partner on Alzheimer’s Drug
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 100 (Table of Contents)
Published: 3 Sep-2008
DOI: 10.3833/pdr.v2008.i100.132 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Pfizer has paid US$725 M for Medivation’s Alzheimer’s drug, Dimebon™...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS